Valeant Pharmaceuticals International, Inc. (T:VRX*CA)

Business Focus: N/A

Nov 08, 2017 08:30 am ET
EyeGate Completes Enrollment in Phase 2b Clinical Trial of EGP-437 for Cataract Surgery
Triggers Milestone Payment under Global Licensing Agreement with Valeant Pharmaceuticals
Jul 14, 2017 06:15 pm ET
S&P Dow Jones Indices Announces Changes to the S&P/TSX Canadian Indices
Results of the Quarterly Review of the S&P/TSX Composite Buyback and Shareholder Yield Indices
Jul 06, 2016 01:39 am ET
Bausch + Lomb and Nicox Announce the Publication of Latanoprostene Bunod Ophthalmic Solution 0.024% Phase 3 Study Results in American Journal of Ophthalmology
LAVAL, Quebec and SOPHIA ANTIPOLIS, France, July 6, 2016 (GLOBE NEWSWIRE) -- Valeant Pharmaceuticals International, Inc.'s (NYSE: VRX and TSX: VRX) wholly owned subsidiary, Bausch + Lomb, a leading global eye health company, and Nicox S.A. (Euronext Paris: COX) today announced that the results of a Phase 3 study for latanoprostene bunod (LBN) ophthalmic solution 0.024% have been published in the American Journal of Ophthalmology. LBN 0.024% is an intraocular pressure (IOP) lowering single-agent eye drop dosed once daily for patients with open angle glaucoma (OAG) or ocular hypertension (OHT). ...
Apr 29, 2016 10:49 am ET
IIROC Trade Resumption - VRX
TORONTO, April 29, 2016 /CNW/ - Trading resumes in:
Apr 29, 2016 10:37 am ET
IIROC Trading Halt - VRX
TORONTO, April 29, 2016 /CNW/ - The following issues have been halted by IIROC:
Mar 21, 2016 10:18 am ET
IIROC Trade Resumption - VRX
TORONTO, March 21, 2016 /CNW/ - Trading resumes in:
Mar 21, 2016 10:04 am ET
IIROC Trading Halt - VRX
TORONTO, March 21, 2016 /CNW/ - The following issues have been halted by IIROC:
Mar 21, 2016 09:25 am ET
IIROC Trade Resumption - VRX
TORONTO, March 21, 2016 /CNW/ - Trading resumes in:

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.